Our perspectives

in one place

News

See all
Press release 3 Jun 2024

Pharmaceutical industry response to pandemic preparedness agreements at World Health Assembly

On 1 June, member states represented at the World Health Assembly agreed on amendments to the International Health Regulations (2005), alongside the decision to complete negotiations on a pandemic agreement within a year. The pharmaceutical industry shared its response.

Read more
Statement 28 May 2024

WHA77 individual statement on the Working Group on Amendments to the International Health Regulations (2005)

On 28 May 2024, IFPMA submitted a statement at the World Health Assembly on Provisional Agenda Item 13.3, Working Group on Amendments to the International Health Regulations (2005). IFPMA acknowledges and appreciates the substantial efforts made by Member States in advancing the text of the Working Group on Amendments to the International Health Regulations (WGIHR)....

Read more
Statement 28 May 2024

WHA77 constituency statement on INB

On 28 May 2024, IFPMA, GSCF, GMTA, DVCMN, and BIO submitted a statement to the World Health Assembly on Provisional Agenda Item 13.4, Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness, and response.

Read more
Statement 27 May 2024

WHA77 constituency statement on NCDs and UHC

On 27 May 2024, IFPMA, IGBA, DITTA, GSCF, WHL, and PATH submitted a constituency statement to the World Health Assembly on Provisional Agenda Item 11.2, NCDs and UHC. IFPMA, IGBA, DITTA, GSCF, WHL, and PATH welcome the agenda item on non-communicable diseases (NCDs) and WHO’s continued commitment to this global health challenge. A life-course approach...

Read more
Statement 27 May 2024

WHA77 individual statement on antimicrobial resistance (AMR)

On 27 May 2024, IFPMA submitted a statement to the World Health Assembly on Provisional Agenda Item 11.8, Antimicrobial resistance. We are broadly supportive of the three strategic priorities described previously and welcome the newly included elevated strategic priority on effective governance and financing, which also recognizes the important role of all stakeholders, including the...

Read more
Statement 27 May 2024

WHA77 individual statement on climate change and health

On 27 May 2024, IFPMA submitted a statement to the World Health Assembly on Provisional Agenda Item 15.4, Climate change and health. IFPMA commends the Resolution and the recognition of climate change as an urgent global challenge. Innovative pharmaceutical companies are setting ambitious, science-aligned targets and investing to develop environmentally sustainable products, manufacturing processes, and...

Read more

Join our media mailing list

If you're a journalist, please join our mailing list to receive regular press notifications.

    Top